PARADIGM CAPITAL MANAGEMENT INC/NY

Position in MDXG — Mimedx Group, Inc.

CIK 1037792 ALBANY, NY

Position in MDXG

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$13,470,685

-$3,123,939 QoQ

Shares Held

3,410,300

+39.1% QoQ

Ownership

2.29%

of shares outstanding

% of Portfolio

0.52%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

16 quarters on record

Voting authority Sole 91.20311996012082.ToString("F0")% Shared 8.79688003987919.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PARADIGM CAPITAL MANAGEMENT INC/NY holds $14,116,985 across 2 Biotechnology names. MDXG ranks #1 (95.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	MDXG	Mimedx Group, Inc. This page	3,410,300	$13,470,685
2	HALO	Halozyme Therapeutics, Inc.	10,000	$646,300

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,470,685	3,410,300	+39.1%	Shares	Defined	2026-05-14
2025-12-31	$16,594,624	2,451,200	-7.5%	Shares	Sole	2026-02-12
2025-09-30	$18,505,376	2,651,200	-40.5%	Shares	Defined	2025-11-14
2025-06-30	$27,204,139	4,452,396	-4.9%	Shares	Defined	2025-08-14
2025-03-31	$35,594,600	4,683,500	-0.1%	Shares	Defined	2025-05-15
2024-12-31	$45,081,542	4,686,231	+0.5%	Shares	Defined	2025-02-18
2024-09-30	$27,564,831	4,664,100	+11.9%	Shares	Sole	2024-11-14
2024-06-30	$28,878,696	4,167,200	+6.6%	Shares	Sole	2024-08-14
2024-03-31	$30,095,450	3,908,500	+13.9%	Shares	Sole	2024-05-15
2023-12-31	$30,084,608	3,430,400	-1.4%	Shares	Sole	2024-02-13
2023-09-30	$25,372,116	3,480,400	0.0%	Shares	Sole	2023-11-13
2023-06-30	$23,005,444	3,480,400	+0.9%	Shares	Sole	2023-08-14
2023-03-31	$11,765,870	3,450,402	+87.0%	Shares	Sole	2023-05-12
2022-12-31	$5,129,934	1,845,300	+62.3%	Shares	Sole	2023-02-03
2022-09-30	$3,264,051	1,137,300	+2544.9%	Shares	Sole	2022-10-26
2022-06-30	$149,210	43,000	—	Shares	Defined	2022-08-02
No filing history on record for this holder in this stock.